What is SpyGlass Pharma (NAS: SGP) worth?
$510.6Mlast known valuation
SpyGlass Pharma (NAS: SGP) last raised $75.0M in its Later Stage VC (Series D) (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for SpyGlass Pharma (NAS: SGP)
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Later Stage VC (Series D) | $75.0M | ▮ | ▮ |
| Jul 2023 | Later Stage VC (Series C) | $90.0M | ▮ | ▮ |
How SpyGlass Pharma (NAS: SGP)'s valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For SpyGlass Pharma (NAS: SGP), too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is SpyGlass Pharma (NAS: SGP) worth?
- SpyGlass Pharma (NAS: SGP)'s last known valuation is $510.6M.
- How much has SpyGlass Pharma (NAS: SGP) raised?
- SpyGlass Pharma (NAS: SGP) has raised $348.5M in total funding across 2 recorded rounds.
- When did SpyGlass Pharma (NAS: SGP) last raise?
- SpyGlass Pharma (NAS: SGP) last raised in Jun 2025 (Later Stage VC (Series D)), raising $75.0M.